Mild Cognitive Impairment  >>  galantamine hydrobromide  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
galantamine hydrobromide / Generic mfg.
NCT00297414: An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

Completed
N/A
1083
US, Canada, Europe, RoW
No intervention
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Mild Cognitive Impairment
01/05
01/05

Download Options